November 2012 FDA Recall Vivitrol by Alkermes, Inc.
D-819-2013 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Alkermes, Inc. on November 6, 2012 for the product Vivitrol. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-819-2013

Reason for Recall
Lack of Assurance of Sterility: Product did not meet the criteria for container closure integrity testing during routine 24 month stability testing.
Initiated
11-06-2012
Reported
07-31-2013
Quantity
3,325 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
VIVITROL (naltrexone for extended-release injectable suspension) a) 380 mg vial NDC 65757-303-02, b) 380 mg vial in kit NDC 65757-300-01, Rx Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451,

Batch or Lot Expiration Information

Lot# Individual vial lot 402-3683AA, EXP 10/13; kit vial lot 2011-003, EXP 08/13

Affected Packages Involved in this Recall